Thank you for reaching out.
We’ll get back to you shortly.

Thank you for reaching out.
We’ll get back to you shortly.

Contact Us

How microscopic ‘condensates’ in cells might contribute to autism

A controversial take on cell biology has gained momentum over the past decade: It’s the idea that one of the fundamental ways cells organize their contents is via tiny droplets that form like oil in water.

These droplets, called biomolecular condensates, corral proteins and other molecules into small compartments within a cell, proponents of the theory say. The arrangement helps cells function more efficiently because it increases the likelihood that the molecules will interact — much as moving a backyard barbeque to a cramped kitchen results in more bumps and spills.

The process by which condensates form — they are bound by molecules that can link up or dissolve as needed — is called phase separation. And it has been implicated in controlling gene function, reshaping connections between neurons, and many other cellular activities — leading some researchers to call it “cell biology 2.0.”

Some experts say the theory is overblown: These condensates exist, but they are not as widespread or as important as some claim. Others argue that condensates hold the potential to revolutionize research and drug development.

Julie Forman-Kay, program head in molecular medicine at the Hospital for Sick Children in Toronto, Canada, and her colleagues made the case that dysfunction of condensates could contribute to a number of conditions, including autism, in a paper this past December.

Forman-Kay spoke with Spectrum about the controversy surrounding condensates, why they might be important for cell function, and how they could answer some central questions in autism research.

Spectrum: What are condensates, and what causes them to form?

Julie Forman-Kay: A condensate is a dense concentration of biomolecules — particularly proteins, and nucleic acids such as RNA and DNA. Condensates require surface tension that defines a boundary between inside and outside.

Getting condensates to form in a test tube is easy using molecules prone to phase separation, and often the number of molecules that you need to do that is actually really small. In some cases, all you have to do is increase the concentration of a particular molecule, and boom, you’ve got a condensate. Or, put a molecular tag on a protein, and boom, the condensate disappears. It’s really fast and easy to regulate their presence experimentally, and it would make sense for nature to exploit this process.

A lot of this process is driven by the presence of ‘intrinsically disordered regions’ in proteins.

S: How do intrinsically disordered regions (IDRs) in proteins contribute to phase separation?

JF-K: Disordered regions are stretches of a protein that don’t have a fixed structure, making it easier for them to bind together with other proteins.

One type of disordered region that is important for phase separation contains multiple segments that are recognized by other proteins with multiple folded binding domains. Another type, called a ‘low-complexity’ region, has no clear binding segments for these folded domains but interacts with other regions just via chemical groups. I am most interested in this class because they are less well-understood and are quite common.

If something goes wrong with those low-complexity regions, though, that can change how condensates form. There are three main ways that mutations in these kinds of IDRs can affect condensates.

The first involves a mutation that alters the concentration of the molecules needed to form a condensate. This type of mutation can cause condensates to form when they shouldn’t, or stop condensates from forming when they should.

Another way is that mutations can change the condensate’s partitioning, causing it to bring in or exclude things it shouldn’t.

And then, very importantly, mutations can change the material property of a protein region so that a condensate that’s supposed to be more liquid and flexible ends up being more viscous and inflexible, or vice versa.

S: What made you and your colleagues think that mutations in IDRs might play a role in autism?

JF-K: First of all, because so many biological processes that likely involve condensates — chromosome organization, transcription, splicing, translational regulation, signaling from the synapse, receptor activation — have been highlighted as mechanistically connected to autism.

Another reason is that we can use bioinformatic algorithms to predict the disordered regions that are present in proteins encoded by genes associated with autism. And we can also try to predict whether those disordered regions might be involved in phase separation.

Using those tools — which aren’t perfect, and which only consider a subset of situations that would lead to phase separation — we have found that the proteins encoded by autism-linked genes are especially enriched for those predicted to phase separate.

And so, with that, we went in and looked at some of these individual proteins [including those encoded by CHD8, DYRK1A, FMR1, SHANK1, SHANK2 and SHANK3] and tried to link what was found in the literature about their potential mechanistic roles to the insights about the role of condensates in those biological processes that I talked about before.

S: What did you learn from that?

JF-K: Autism is like a lot of complex conditions for which scientists often don’t understand how a given mutation can really have a mechanistic effect — what is sometimes called ‘missing heritability.’ If you understand the biophysics of condensates as having contributions from all of the different components in that condensate, then you can understand that little mutations, by themselves, may not have an effect. But if you’ve got enough proteins that are mutated all together within the same condensate that shift the biophysics in one direction, then you can have pathology.

S: Some researchers have been critical of condensate research, calling it sloppy science.” What are your thoughts on that?

JF-K: Some of the debates are really, in some sense, semantics. And in some ways, they’re also dependent on technology and the resolution of the optical imaging tools that you can apply.

A lot of the debates are also based on misconceptions about biophysics. Some people are arguing that there are physical models for what phase separation would predict, and they don’t see that in the cell. Well, those physical models are simplistic and rely on assumptions for a single component. And they break down when you have hundreds of components.

And there may be a political aspect to this, too: People who hold the original paradigm view are not so happy with those people who bring forward a new paradigm, and there’s a struggle.

S: If problems with phase separation are at the root of autism or other conditions, what are the implications for treatment?

JF-K: There has been a real growth in the pharmaceutical industry, in terms of their understanding of condensates and targeting condensates. Several established and new drug companies — Dewpoint and Faze Medicines as well as others — aim to treat conditions by targeting the pathological effects of condensates.

One idea is to identify small molecules that could go to those condensates to either dissolve them or strengthen them. Or a small molecule that affects an enzyme that controls post-translational modifications could help regulate the formation or disassembly of a condensate.

Autism is challenging because it can cause many different condensates to have regulation that is just off, and not always in the same direction. You know, autism has been referred to as a condition of poorly regulated [protein] translation — but not specifically over-translation or under-translation. Because if you go either over or under, you can get autism traits. So you really need some fine-tuning of regulation.

I think that understanding more where that regulatory set point is will be helpful. And then having small-molecule libraries that that can be tuned and developed to be enriched in particular condensates that could change their properties will give us a tool kit for thinking about it. But you know, it’s not a ‘tomorrow’ solution.

The post How microscopic ‘condensates’ in cells might contribute to autism appeared first on Spectrum | Autism Research News.

related articles

User Pic

New measures of social skills tap what monkeys see, do

Monkey vision: The amount of time a macaque spends looking at social aspects of images,...

User Pic

Mice with autism-related mutations show brain signaling imbalance

Mutations in POGZ, a gene strongly linked to autism, lead to a signaling imbalance in m...

User Pic

Anxiety, self-harm elevated in people with DDX3X syndrome

Self-harm: Almost half of girls and women with DDX3X syndrome bang their head, often in...

User Pic

Autism and eating disorders may have an emotional connection

Eating disorders have the highest mortality rates of any kinds of mental illness. They ...


google analytics policy

we may collect information about your computer, including your IP address, operating system and browser type, for system administration and in order to create reports. This is statistical data about our users' browsing actions and patters, and does not identify any individual.

The only cookies in use on our site are for Google Analytics. Google Analytis is aweb analytics tool that helps website owners understand how visitors engage with their website. GoogleAnalytics customers can view a variety of reports about how visitors interact with their website so that they can improve it.

Like many services, Google Analytics users first-party cookies to track visitor interactions as in our case, where they are used to collect information about how visitors use our site. We then use the information to compile reports and to help use improve our site.

Cookies contain information that is transferred to your computer's hard drive. These cookies are used to store information, such as the time that the current visit occured, whether the visitor has been to the site before and what site referred the visitor to the web page.

Google Analyticsw collets information anonymously. It reports website trends without identifying individual visitors. you can opt out of Google Analytics without affecting how your visit our site- for more information on opting our of being tracked by Google Analytics across all websites you use, visit this Google page


hipaa privacy

Compleat KiDZ


If you have any questions about this Notice of Privacy Practices, please contact our Privacy Officer, by telephone at (704) 824-7800 or in writing at 2675 Court Drive, Gastonia, NC 28054.
This Notice of Privacy Practices describes how we may use and disclose your protected health information to carry out treatment, payment or health care operations and for other purposes that are permitted or required by law. It also describes your rights to access and control your protected health information. Protected health information is information about you, including demographic information, that may identify you and that relates to your past, present or future physical or mental health or condition and related health care services.


We are required to abide by the terms of this Notice of Privacy Practices. We may change the terms of our Notice of Privacy Practices at any time. The new Notice of Privacy Practices will be effective for all protected health information that we maintain at that time. Upon your request, we will provide you with any revised Notice of Privacy Practices. You may request a revised version by calling or writing our Privacy Officer and requesting that a revised copy be sent to you in the mail or asking for one at the time of your next appointment.


Your protected health information may be used and disclosed by our office staff others outside of our office who are involved in your care and treatment for the purpose of providing health care services to you.
Your protected health information may also be used and disclosed to pay your health care bills and to support the operation of our practice.
Following are examples of the types of uses and disclosures of your protected health information that we are permitted to make. These examples are not meant to be exhaustive, but to describe the types of uses and disclosures that may be made by our office.

1. Treatment: We will use and disclose your protected health information to provide, coordinate, or manage your health care and any related services. This includes the coordination or management of your health care with another provider.
For example, we would disclose your protected health information, as necessary, to a home health agency that provides care to you. We will also disclose protected health information to other healthcare providers who may be treating you.
For example, your protected health information may be provided to a physician to whom you have been referred to ensure that the physician has the necessary information to diagnose or treat you. In addition, we may disclose your protected health information from time-to-time to other health care providers (e.g., a specialist or laboratory) who become involved in your care by providing assistance with your health care diagnosis or treatment to us.
2. Payment: We may use and disclose protected health information about you so that the treatment and services you receive at Compleat KiDZ may be billed to and payment may be collected from you, an insurance company, or a third party. This may include certain activities that your health insurance plan may undertake before it approves or pays for the health care services we recommend for you such as: making a determination of eligibility or coverage for insurance benefits, and reviewing services provided to you for medical necessity. For example, if you have a back injury, we may need to give your health plan information about your condition, supplies used, and services you received.
3. Healthcare Operations: We may use or disclose, as needed, your protected health information for healthcare operations. These uses and disclosures are necessary to run Compleat KiDZ and make sure that all of our patients receive quality care. For example, we ma)'use protected health information to review our treatment and services and to evaluate the performance of our staff in caring for you. We may also combine protected health information about many patients to decide what additional services Compleat KiDZ should offer, what services are not needed, and whether certain new treatments are effective. We may also disclose information to doctors, nurses, technicians, medical students, and other personnel for review and learning purposes, we may remove information that identifies you from this set of protected health information so others may use it to study health care and health care delivery without learning the identities of specific patients.
We may share your protected health information with third party "business associates" that perform various activities (for example, billing or transcription services) for our practice. Whenever an arrangement between our practice and a business associate involves the use or disclosure of your protected health information, we will have a written contract that contains terms that will protect the privacy of your protected health information.
We may use and / or disclose protected health information to contact you to, remind you about an appointment you have for treatment or medical care.
We may use or disclose your protected health information, as necessary, to provide you with information about treatment alternatives or other health--related benefits and services that may be of interest to you. You may contact our Privacy Officer to request that these materials not be sent to you.
4. Other Permitted and Required Uses and Disclosures That May Be Made Without Your Authorization or Opportunity to Agree and Object:
We may use or disclose your protected health information in the following situations without your authorization or providing you the opportunity to agree or object. These situations include:
(i) Required by Law: We may use or disclose your protected health information to the extent that the use or disclosure is required by law. The use or disclosure will be made in compliance with the law and will be limited d to the relevant requirements of the law. You will be notified, if required by law, of any such uses or disclosures.

(ii) Public Health: We may disclose your protected health information for public health activities and purposes to a public health authority that is permitted by law to collect or receive the information. For example, a disclosure may be made for the purpose of preventing or controlling disease, injury or disability.

(iii) Communicable Diseases: We may disclose your protected health information, if authorized by law, to a person who may have been exposed to a communicable disease or may otherwise be at risk of contracting or spreading the disease or condition.

(iv) Health Oversight: We may disclose protected health information to a health oversight agency for activities authorized by law, such as audits, investigations, and inspections. Oversight agencies seeking this information include government agencies t-rat oversee the health care system, government benefit programs, other government regulatory programs and civil rights laws.

(v) Abuse or Neglect: We may disclose your protected health information to a public health authority that is authorized by law to receive reports of child abuse or neglect. In addition, we may disclose your protected health information if we believe that you have been a victim of abuse, neglect or domestic violence to the governmental entity or agency authorized to receive such information. In this case, the disclosure will be made consistent with the requirements of applicable federal and state laws.

(vi) Legal Proceedings: We may disclose protected health information in the course of any judicial or administrative proceeding, in response to an order of a court or administrative tribunal (to the extent such disclosure is expressly authorized), or in certain conditions in response to a subpoena, discovery request or other lawful process.

(vii) Law Enforcement: We may also disclose protected health information, so long as applicable legal requirements are met, for law enforcement purposes, these law enforcement purposes include (1) legal processes and otherwise required by law, (2) limited information requests for identification and location purposes, (3) pertaining to victims of a crime, (4) suspicion that death has occurred as a result of criminal conduct, (5) in the event that a crime occurs on the premises of our practice, and (6) medical emergency (not on our premises) and it is likely that a crime has occurred.

(viii) Research: We may disclose your protected health information to researchers when their research has been approved by an institutional review board that has reviewed the research proposal and established protocols to ensure the privacy of your protected health information.

(ix) Criminal Activity: Consistent with applicable federal and state laws, we may disclose your protected health information, if we believe that the use or disclosure is necessary to prevent or lessen a serious and imminent threat to the health or safety of a person or the public. We may also disclose protected health information if it is necessary for law enforcement authorities to identify or apprehend an individual.

(x) Military Activity and National Security: When the appropriate conditions apply, we may use or disclose protected health information of individuals who are Armed Forces personnel (1) for activities deemed necessary by appropriate military command authorities; (2) for the purpose of a determination by the Department of Veterans Affairs of your eligibility for benefits, or (3) to foreign military authority if you are a member of that foreign military services. We may also disclose your protected health information to authorized federal officials for conducting national security and intelligence activities, including for the provision of protective services to the President or others legally authorized.

(xi) Workers' Compensation: We may disclose your protected health information as authorized to comply with workers' compensation laws and other similar legally established programs.
5. Other Permitted and Required Uses of Disclosures That Require Providing You the Opportunity to Agree or Object
We may use and disclose your protected health information in the following instances. You have the opportunity to agree or object to the use or disclosure of all or part of your protected health information. If you are not present or able to agree or object to the use or disclosure of the protected health information, then we may, using professional judgment, determine whether the disclosure is in your best interest.

Others Involved in Your Health Care or Payment for our Care:

Unless you object, we may disclose to a member of your family, a relative, a close friend or any other person you identify, your protected health information that directly relates to that person's involvement in your health care. If you are unable to agree or object to such a disclosure, we may disclose such information as necessary if we determine that it is in your best interest based on our professional judgment. We may use or disclose protected health information to notify or assist in notifying a family member, personal representative or any other person that is responsible for your care of your location, general condition or death. Finally, we may use or disclose your protected health information to an authorized public or private entity to assist in disaster relief efforts and to coordinate uses and disclosures to family or other individuals involved in your health care.
6. Uses and Disclosures of Protected Health Information Based upon Your Written Authorization Other uses and disclosures of your protected health information will be made only with your written authorization, unless otherwise permitted or required by law as described below. You may revoke this authorization in writing at any time. If you revoke your authorization, we will no longer use or disclose your protected health information for the reasons covered by your written authorization. Please understand that we are unable to take back any disclosures already made with your authorization.
Following is a statement of your rights with respect to your protected health information and a brief description of how you may exercise these rights
1. You have the right to inspect and copy your protected health information
This means you may inspect and obtain a copy of protected health information about you for so long as we maintain the protected health information. You may obtain your medical record that contains medical and billing records and any other records that we use for making decisions about you. As permitted by federal or state law, we may charge you a reasonable copy fee for a copy of your records.
2. You have the right to request a restriction of your protected health information
This means you may ask us not to use or disclose any part of your protected health information for the purposes of treatment, payment or health care operations. You may also request that any part of your protected health information not be disclosed to family members or friends who may be involved in your care or for notification purposes as described in this Notice of Privacy Practices. Your request must state the specific restriction requested and to whom you want the restriction to apply.

We are not required to agree to a restriction that you may request. If we agree to the requested restriction, we may not use or disclose your protected health information in violation of that restriction unless it is needed to provide emergency treatment. With this in mind, please discuss any restriction you wish to request with your health provider.

You may request a restriction by making your request in writing to our Privacy Officer. In your request, you must tell us (1) what information you want to limit; (2) whether you want to limit our use, disclosure, or both; and (3) to whom you want the limits to apply, for example, disclosures to your spouse.
3. You have the right to request to receive confidential communications from us by alternative means or at an alternative location
We will accommodate reasonable requests. We may also condition this accommodation by asking you for information as to how payment will be handled or specification of an alternative address or other method of contact. We will not request an explanation from you as to the basis for the request. Please make this request in writing to our Privacy Officer.
4. Your may have right to amend your protected health information
This means you may request an amendment of protected health information about you in a designated record set for so long as we maintain this information. In certain cases, we may deny your request for an amendment. If we deny your request for amendment, you have the right to file a statement of disagreement with us and we may prepare a rebuttal to your statement and will provide you with a copy of any such rebuttal. Please contact our Privacy Officer if you have questions about amending your medical record.
5. You have the right to receive an accounting of certain disclosures we have made, if any, of your protected health information This right applies to disclosures for purposes other than treatment, payment or health care operations as described in this Notice of Privacy Practices. It excludes disclosures we may have made to you if you authorized us to make the disclosure, to family members or friends involved in your care, or for notification purposes, for national security or intelligence, to law enforcement (as provided in the privacy rule) or correctional facilities, as part of a limited data set disclosure. The right to receive this information is subject to certain exceptions, restrictions and limitations.
6. You have the right to obtain a paper copy of this notice from us
upon request, even if you have agreed to accept this notice electronically.
You may complain to us or to the Secretary of Health and Human Services if you believe your privacy rights have been violated by us. You may file a complaint with us by notifying our Privacy Officer of your complaint. We will not retaliate against you for filing a complaint

You may contact our Privacy Officer at (704) 824-7800 for further information about the complaint process.

This notice was published and becomes effective on August l, 2011.